TNS NIPO study underlines need for wide-scale, reliable prostate cancer screening

A recent TNS NIPO survey, on behalf of the Dutch Association of Urology (NVU) and the European Association of Urology (EAU), showed that almost four out of 10 Dutch men of 50 years and older suffer, or have suffered, from urinary complaints. The same number of men also said in the same survey they are worried that they may have prostate cancer.

The TNS NIPO survey also indicated that a significantly larger number of men that suffer, or have suffered, from urinary complaints expressed the concern of having prostate cancer as compared to men without urinary complaints. Hundreds of thousands of men suffer from prostate complaints, however, many of them often do not seek medical help because they see them as a normal part of growing older or because their complaints do not hamper them in daily life.

Of note was the survey finding that practically all men who have participated in the Dutch study said that they would prefer to have an annual check or screening for prostate cancer. The widely used screening called the Prostate-Specific Antigen (PSA) test, however, is not known to the vast majority of survey participants. The conclusion is that reliable information is urgently needed.

The study results will be released today, 15 September, during the annual official European prostate awareness day, part of the ongoing Urology Week activities. The Dutch and European associations for urologists (NVU and EAU) are collaborating to inform people about the prostate and the most common prostate-related diseases that affect many men.

A public information campaign will be held in downtown Amsterdam. At the Dam square right on the central shopping district, a walk-through, giant model of a prostate is displayed to acquaint the general public of the prostate and its ailments. Urologists will be available to answer questions from the public.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy